WASL and Alzheimer disease: We found that the expression of N-WASP was reduced by 50% in AD patients (n = 10) compared to healthy individuals (n = 10) (Fig. S5), however the difference was not statistically significant probably because of biological variance in the expression of N-WASP and the small number of subjects.